Gossamer Bio (GOSS) Short Interest Ratio & Short Volume $0.71 -0.01 (-1.38%) (As of 11/19/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Gossamer Bio Short Interest DataGossamer Bio (GOSS) has a short interest of 6.30 million shares. This marks a -9.35% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.8, indicating that it would take 7.8 days of the average trading volume of 1.43 million shares to cover all short positions.Current Short Interest6,300,000 sharesPrevious Short Interest6,950,000 sharesChange Vs. Previous Month-9.35%Dollar Volume Sold Short$5.53 millionShort Interest Ratio7.8 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares226,604,000 sharesPercentage of Shares Shorted2.78%Today's Trading Volume1,133,162 sharesAverage Trading Volume1,429,023 sharesToday's Volume Vs. Average79% Short Selling Gossamer Bio? Sign up to receive the latest short interest report for Gossamer Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGOSS Short Interest Over TimeGOSS Days to Cover Over TimeGOSS Percentage of Float Shorted Over Time Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Gossamer Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20246,300,000 shares $5.53 million -9.4%N/A7.8 $0.88 10/15/20246,950,000 shares $6.73 million -10.3%N/A7.7 $0.97 9/30/20247,750,000 shares $7.64 million -9.4%N/A7 $0.99 9/15/20248,550,000 shares $7.88 million -5.8%N/A5.6 $0.92 8/31/20249,080,000 shares $7.97 million -5.2%N/A4.6 $0.88 8/15/20249,580,000 shares $7.90 million -0.4%N/A4.7 $0.82 Get the Latest News and Ratings for GOSS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter. 7/31/20249,620,000 shares $8.69 million +4.7%N/A4.4 $0.90 7/15/20249,190,000 shares $10.84 million -4.6%N/A3.8 $1.18 6/30/20249,630,000 shares $8.68 million -3.5%N/A4.2 $0.90 6/15/20249,980,000 shares $5.19 million -24.4%N/A4.3 $0.52 5/31/202413,200,000 shares $7.79 million +4.9%N/A8.1 $0.59 5/15/202412,580,000 shares $9.34 million -2.1%N/A7.6 $0.74 4/30/202412,850,000 shares $9.12 million +15.7%N/A7.6 $0.71 4/15/202411,110,000 shares $9.53 million +3.3%N/A8.5 $0.86 3/31/202410,760,000 shares $12.70 million -3.0%N/A8.7 $1.18 3/15/202411,090,000 shares $16.19 million -22.5%N/A10.3 $1.46 2/29/202414,300,000 shares $20.16 million -6.5%N/A11.2 $1.41 2/15/202415,300,000 shares $15.76 million -8.5%N/A11.1 $1.03 1/31/202416,720,000 shares $14.04 million -3.6%N/A11.6 $0.84 1/15/202417,350,000 shares $16.89 million -1.2%N/A9.5 $0.97 12/31/202317,560,000 shares $16.02 million -6.7%N/A8.8 $0.91 12/15/202318,820,000 shares $19.20 million -16.7%N/A9.1 $1.02 11/30/202322,580,000 shares $17.66 million +1.9%N/A10.2 $0.78 11/15/202322,160,000 shares $17.97 million +10.6%N/A10.2 $0.81 10/31/202320,030,000 shares $10.02 million -14.6%N/A9.9 $0.50 10/15/202323,440,000 shares $15.14 million -1.7%N/A12.1 $0.65 9/30/202323,850,000 shares $19.86 million +18.2%N/A10.8 $0.83 9/15/202320,170,000 shares $18.56 million +2.0%N/A8.8 $0.92 8/31/202319,770,000 shares $20.56 million -3.3%N/A8.3 $1.04 8/15/202320,450,000 shares $23.31 million +1.6%N/A8.4 $1.14 7/31/202320,130,000 shares $27.18 million +37.2%34.3%8.1 $1.35 7/15/202314,670,000 shares $21.86 million +2.2%19.6%6.1 $1.49 6/30/202314,360,000 shares $17.23 million -11.6%19.2%6.7 $1.20 6/15/202316,250,000 shares $22.26 million +6.5%21.8%7.3 $1.37 5/31/202315,260,000 shares $20.45 million -3.2%20.5%5.2 $1.34 5/15/202315,770,000 shares $18.77 million -3.1%21.1%4.9 $1.19 4/30/202316,280,000 shares $21.00 million -5.0%23.4%5 $1.29 4/15/202317,130,000 shares $17.90 million +0.4%23.1%4.7 $1.05 3/31/202317,060,000 shares $21.50 million -30.4%23.0%4.4 $1.26 3/15/202324,520,000 shares $32.37 million -7.9%32.6%5.6 $1.32A huge crack is forming in the US economy (Ad)Former Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.”Learn how to protect yourself too, click here. 2/28/202326,620,000 shares $46.05 million +5.4%35.6%4.5 $1.73 2/15/202325,250,000 shares $59.34 million -0.4%33.8%4.4 $2.35 1/31/202325,350,000 shares $66.92 million -6.7%35.8%4.5 $2.64 1/15/202327,170,000 shares $63.58 million +1.0%38.3%5.1 $2.34 12/30/202226,890,000 shares $58.35 million +86.6%38.0%5.5 $2.17 12/15/202214,410,000 shares $30.26 million -32.9%20.3%3.2 $2.10 11/30/202221,470,000 shares $183.78 million +12.2%30.4%7.4 $8.56 11/15/202219,130,000 shares $191.49 million +0.8%27.1%14.7 $10.01 10/31/202218,980,000 shares $210.68 million +7.5%N/A15.7 $11.10 10/15/202217,660,000 shares $214.92 million +1.7%N/A15.1 $12.17 9/30/202217,370,000 shares $208.09 million +4.6%24.0%11.2 $11.98 9/15/202216,610,000 shares $229.55 million +3.0%22.9%11.2 $13.82 8/31/202216,130,000 shares $225.01 million +4.3%23.8%11.8 $13.95 8/15/202215,470,000 shares $220.45 million +6.6%22.8%11.6 $14.25 7/31/202214,510,000 shares $162.95 million +7.4%26.7%11 $11.23 7/15/202213,510,000 shares $149.69 million +14.0%24.9%9.6 $11.08 6/30/202211,850,000 shares $99.18 million -2.0%21.8%13.5 $8.37 6/15/202212,090,000 shares $73.87 million +7.8%22.2%14.3 $6.11 5/31/202211,220,000 shares $79.10 million -2.4%20.7%13.9 $7.05 5/15/202211,500,000 shares $98.90 million +10.2%21.2%13.8 $8.60 4/30/202210,440,000 shares $72.14 million -9.4%19.7%13.4 $6.91 4/15/202211,520,000 shares $101.95 million -2.7%21.7%15.8 $8.85 3/31/202211,840,000 shares $102.77 million -1.8%22.3%18.4 $8.68 3/15/202212,060,000 shares $101.79 million -0.8%22.7%19.3 $8.44 2/28/202212,160,000 shares $109.80 million -2.2%22.9%18.4 $9.03 2/15/202212,430,000 shares $113.11 million +0.8%23.5%19.4 $9.10 1/31/202212,330,000 shares $118.24 million +9.3%23.3%20 $9.59 1/15/202211,280,000 shares $133.67 million +2.9%20.4%20.1 $11.85 12/31/202110,960,000 shares $123.96 million +7.9%19.8%20.3 $11.31 12/15/202110,160,000 shares $108.51 million +1.3%18.4%18.2 $10.68 11/30/202110,030,000 shares $108.73 million -0.3%18.2%18.5 $10.84 11/15/202110,060,000 shares $117.30 million +10.4%18.2%19.1 $11.66 10/29/20219,110,000 shares $113.15 million +0.8%16.6%16.1 $12.42 10/15/20219,040,000 shares $127.19 million -2.5%16.5%17 $14.07 9/30/20219,270,000 shares $116.52 million -4.0%16.9%17.7 $12.57 9/15/20219,660,000 shares $100.85 million -3.3%17.6%18.7 $10.44 8/31/20219,990,000 shares $99.30 million -5.3%18.2%19.7 $9.94 8/13/202110,550,000 shares $95.27 million -4.9%19.3%20.5 $9.03 7/30/202111,090,000 shares $87.17 million +8.6%19.8%21.2 $7.86 7/15/202110,210,000 shares $74.74 million +3.1%18.3%20.2 $7.32 6/30/20219,900,000 shares $80.39 million -5.9%17.7%18.6 $8.12 6/15/202110,520,000 shares $90.79 million +1.2%18.7%20.5 $8.63 5/28/202110,400,000 shares $88.09 million -0.8%18.5%19.2 $8.47 5/14/202110,480,000 shares $88.66 million -3.2%18.7%17 $8.46 4/30/202110,830,000 shares $94.22 million -3.2%19.3%17.4 $8.70 4/15/202111,190,000 shares $95.45 million +1.2%20.1%16.5 $8.53 3/31/202111,060,000 shares $95.45 million +32.1%19.8%16.4 $8.63 3/15/20218,370,000 shares $89.06 million +6.2%14.9%11.9 $10.64 2/26/20217,880,000 shares $77.15 million +3.0%14.1%10.1 $9.79 2/12/20217,650,000 shares $81.55 million +18.8%13.5%10.6 $10.66A huge crack is forming in the US economy (Ad)Former Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.”Learn how to protect yourself too, click here. 1/29/20216,440,000 shares $62.92 million -14.7%11.5%9.3 $9.77 1/15/20217,550,000 shares $79.28 million -4.3%13.4%11.3 $10.50 12/31/20207,890,000 shares $77.95 million +2.6%14.0%8.4 $9.88 12/15/20207,690,000 shares $81.13 million -8.1%13.7%8.3 $10.55 11/30/20208,370,000 shares $75.16 million +4.1%14.9%10.5 $8.98 11/15/20208,040,000 shares $73.57 million -19.8%14.3%10.6 $9.15 10/30/202010,030,000 shares $86.26 million -3.7%17.9%13.6 $8.60 10/15/202010,420,000 shares $97.17 million +5.7%18.6%14.3 $9.33 9/30/20209,860,000 shares $122.36 million +21.1%17.5%20.9 $12.41 9/15/20208,140,000 shares $105.90 million +0.6%14.5%16.3 $13.01 8/31/20208,090,000 shares $112.45 million -0.6%14.4%15.5 $13.90 8/14/20208,140,000 shares $113.39 million +3.4%14.5%13.9 $13.93 7/31/20207,870,000 shares $93.81 million +9.5%16.3%10.4 $11.92 7/15/20207,190,000 shares $95.63 million +24.0%14.9%9.9 $13.30 6/30/20205,800,000 shares $73.14 million +1.9%12.0%8.7 $12.61 6/15/20205,690,000 shares $71.07 million -2.7%11.8%9 $12.49 5/29/20205,850,000 shares $71.08 million +29.4%12.8%9.5 $12.15 5/15/20204,520,000 shares $63.91 million -4.4%9.9%7.6 $14.14 4/30/20204,730,000 shares $61.58 million -5.8%10.8%11.7 $13.02 4/15/20205,020,000 shares $55.72 million +1.8%11.5%12.1 $11.10 3/31/20204,930,000 shares $66.01 million -2.3%11.3%11.1 $13.39 3/13/20205,047,000 shares $57.99 million -2.4%20.3%11.6 $11.49 2/28/20205,170,000 shares $48.49 million -2.8%20.8%9.3 $9.38 2/14/20205,320,000 shares $61.18 million -4.8%12.3%9.7 $11.50 1/31/20205,590,000 shares $77.87 million +14.3%13.0%9.9 $13.93 1/15/20204,890,000 shares $73.50 million +11.6%11.4%8.3 $15.03 12/31/20194,380,000 shares $58.39 million +21.0%10.2%7.3 $13.33 GOSS Short Interest - Frequently Asked Questions What is Gossamer Bio's current short interest? Short interest is the volume of Gossamer Bio shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 6,300,000 shares of GOSS short. Learn More on Gossamer Bio's current short interest. What is a good short interest ratio for Gossamer Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GOSS shares currently have a short interest ratio of 8.0. Learn More on Gossamer Bio's short interest ratio. Is Gossamer Bio's short interest increasing or decreasing? Gossamer Bio saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 6,300,000 shares, a decrease of 9.4% from the previous total of 6,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Gossamer Bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Gossamer Bio: Anavex Life Sciences Corp. (21.59%), Immunome, Inc. (21.37%), Entrada Therapeutics, Inc. (7.68%), Nuvation Bio Inc. (4.94%), ORIC Pharmaceuticals, Inc. (16.51%), Stoke Therapeutics, Inc. (12.65%), CorMedix Inc. (10.35%), Exscientia plc (2.55%), Tectonic Therapeutic (4.56%), Annexon, Inc. (7.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Gossamer Bio stock? Short selling GOSS is an investing strategy that aims to generate trading profit from Gossamer Bio as its price is falling. GOSS shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gossamer Bio? A short squeeze for Gossamer Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GOSS, which in turn drives the price of the stock up even further. How often is Gossamer Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GOSS, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Anavex Life Sciences Short Interest Data Immunome Short Interest Data Entrada Therapeutics Short Interest Data Nuvation Bio Short Interest Data ORIC Pharmaceuticals Short Interest Data Stoke Therapeutics Short Interest Data CorMedix Short Interest Data Exscientia Short Interest Data Tectonic Therapeutic Short Interest Data Annexon Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GOSS) was last updated on 11/20/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe Stock Powering Musk’s AI Revolution—RevealedImagine being able to invest in Tesla, PayPal, or SpaceX before the world knew their potential. Today, you ...InvestorPlace | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gossamer Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gossamer Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GOSS Stock Alerts